Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125410541 | 12541054 | 1 | I | 201603 | 20160630 | 20160708 | 20160708 | EXP | US-INDIVIOR LIMITED-INDV-091880-2016 | INDIVIOR | 55.00 | YR | M | Y | 0.00000 | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125410541 | 12541054 | 1 | PS | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Sublingual | 24 MG, DAILY | UNKNOWN | 22410 | |||||||||
| 125410541 | 12541054 | 2 | SS | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Sublingual | 24 MG, DAILY | UNKNOWN | 22410 | |||||||||
| 125410541 | 12541054 | 3 | SS | BELBUCA | BUPRENORPHINE HYDROCHLORIDE | 1 | Sublingual | 150 MCG, ONE TIME DOSE | Y | UNKNOWN | 0 | ||||||||
| 125410541 | 12541054 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, DAILY | 0 | ||||||||||
| 125410541 | 12541054 | 5 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1MG, TWICE A DAY | 0 | ||||||||||
| 125410541 | 12541054 | 6 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, TWICE A DAY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125410541 | 12541054 | 1 | Drug dependence |
| 125410541 | 12541054 | 3 | Drug dependence |
| 125410541 | 12541054 | 4 | Hypertension |
| 125410541 | 12541054 | 5 | Anxiety |
| 125410541 | 12541054 | 6 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125410541 | 12541054 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125410541 | 12541054 | Arthralgia | |
| 125410541 | 12541054 | Bone cancer | |
| 125410541 | 12541054 | Chromaturia | |
| 125410541 | 12541054 | Dyspnoea | |
| 125410541 | 12541054 | Feeling abnormal | |
| 125410541 | 12541054 | Hypersomnia | |
| 125410541 | 12541054 | Neck pain | |
| 125410541 | 12541054 | Prostatitis | |
| 125410541 | 12541054 | Skin burning sensation | |
| 125410541 | 12541054 | Swollen tongue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125410541 | 12541054 | 1 | 201601 | 201603 | 0 | |
| 125410541 | 12541054 | 2 | 201603 | 0 | ||
| 125410541 | 12541054 | 3 | 201603 | 201603 | 0 |